0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

TREATMENT OF RHUS DERMATITIS

Robert J. Hoagland; Henry C. Cosand
JAMA. 1951;146(7):612-614. doi:10.1001/jama.1951.03670070004002.
Text Size: A A A
Published online

Numerous treatments for Rhus dermatitis are mentioned in textbooks of dermatology, and a writer on the subject is likely to be surprised by interest shown by the lay press and by many laymen volunteering cures involving various herbs or chemicals. The many remedies advocated by physicians and the laity testify both to unscientific thinking and to difficulties involved in controlled investigations.

Treatment of 70 patients with ivy dermatitis with tripelennamine (pyribenzamine®) hydrochloride cream and calamine lotion, in the summer of 1949, led to the conclusions that further trials with tripelennamine locally were desirable and that a local anesthetic such as dibucaine (nupercainal®) would be preferable to calamine lotion for comparison with agents believed to have curative effects.1 In addition, investigation of other recommended remedies might result in finding a treatment that could be shown to accelerate recovery from Rhus dermatitis.

Investigation and evaluation of a proposed treatment for ivy

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();